ストックスクリーナーアプリを入手
15.87
6.70%
-1.15
前日終値:
$17.02
開ける：
$16.87
24時間の取引高:
104.82K
Relative Volume:
0.36
時価総額：
$782.37M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+8.03%
1か月 パフォーマンス:
-2.87%
6か月 パフォーマンス:
+82.32%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$15.80
$16.95
1週間の範囲:
$14.30
$17.11
52週間の値動き範囲:
$6.565
$17.71
Jade Biosciences Inc Stock (JBIO) Company Profile
JBIO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
JBIO
Jade Biosciences Inc
|
15.87 | 839.33M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.16 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
751.89 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
815.50 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
362.90 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.94 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Jade Biosciences Inc Stock (JBIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-07 | 開始されました | H.C. Wainwright | Buy |
| 2025-10-09 | 開始されました | BTIG Research | Buy |
| 2025-07-14 | 開始されました | Jefferies | Buy |
| 2025-06-16 | アップグレード | Guggenheim | Neutral → Buy |
| 2025-05-07 | 開始されました | Wedbush | Outperform |
| 2025-05-05 | 開始されました | Stifel | Buy |
| 2025-05-02 | 開始されました | TD Cowen | Buy |
| 2024-06-18 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2024-06-18 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-06-18 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-06-17 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-06-17 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-06-17 | ダウングレード | Wedbush | Outperform → Neutral |
| 2024-03-25 | 再開されました | Jefferies | Buy |
| 2023-12-08 | 開始されました | Wells Fargo | Equal Weight |
| 2023-03-01 | 開始されました | Guggenheim | Buy |
| 2022-12-06 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-09-19 | 再開されました | Wedbush | Outperform |
| 2022-08-16 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-02-11 | 開始されました | BTIG Research | Buy |
| 2021-07-26 | 開始されました | Cowen | Outperform |
| 2021-07-26 | 開始されました | Evercore ISI | Outperform |
| 2021-07-26 | 開始されました | Jefferies | Buy |
| 2021-07-26 | 開始されました | Wedbush | Outperform |
すべてを表示
Jade Biosciences Inc (JBIO) 最新ニュース
What Makes Jade Biosciences, Inc. (JBIO) a New Buy Stock - MSN
H.C. Wainwright Initiates Jade Biosciences (JBIO) at Buy With $25 PT as JADE101 Eyes $926M Peak Revenue - Finviz
Short Interest in Jade Biosciences, Inc. (NASDAQ:JBIO) Increases By 47.9% - MarketBeat
Jade Biosciences, Inc. (NASDAQ:JBIO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Breakout Watch: What is AvePoint Incs TAM Total Addressable MarketMarket Trend Report & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
JBIO: Advancing novel autoimmune therapies with strong data, market potential, and rapid clinical timelines - TradingView — Track All Markets
Valuation Update: What is the PEG ratio of Jade Biosciences IncJuly 2025 PostEarnings & AI Enhanced Trading Alerts - baoquankhu1.vn
Jade Biosciences (NASDAQ:JBIO) Trading Down 4.8%Should You Sell? - MarketBeat
Published on: 2026-01-10 20:20:04 - ulpravda.ru
How risky is Jade Biosciences Inc. stock nowPortfolio Profit Report & Fast Entry and Exit Trade Plans - Улправда
Will Jade Biosciences Inc. stock rally after Fed decisionsJuly 2025 Final Week & Real-Time Chart Pattern Alerts - Улправда
How Jade Biosciences Inc. stock reacts to global recession fearsFit and Size Notes & quick comparison of popular models - Улправда
Equities Analysts Offer Predictions for JBIO FY2025 Earnings - MarketBeat
How Jade Biosciences Inc. stock reacts to job market dataJuly 2025 Breakouts & Accurate Entry and Exit Point Alerts - Улправда
Jade Biosciences (NASDAQ:JBIO) Coverage Initiated at HC Wainwright - Defense World
Why Jade Biosciences Inc. stock is popular among millennialsQuarterly Portfolio Review & Daily Growth Stock Tips - Улправда
Will Jade Biosciences Inc. stock benefit from sector rotationPortfolio Performance Summary & Stepwise Trade Signal Implementation - Улправда
Why Jade Biosciences Inc. stock remains a top recommendationMarket Activity Report & Expert Approved Momentum Ideas - Улправда
Jade Biosciences (NASDAQ:JBIO) Upgraded to Strong-Buy at HC Wainwright - MarketBeat
Jade Biosciences (NASDAQ:JBIO) Shares Gap UpShould You Buy? - MarketBeat
H.C. Wainwright initiates coverage on Jade Biosciences stock with Buy rating - Investing.com India
This Applied Digital Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Benzinga
HC Wainwright & Co. Initiates Coverage of Jade Biosciences (JBIO) with Buy Recommendation - Nasdaq
Wall Street Analysts Predict a 52.5% Upside in Jade Biosciences, Inc. (JBIO): Here's What You Should Know - MSN
Institutional Investors of Jade Biosciences, Inc. (NASDAQ:JBIO) Must Be Disappointed After Last Week's 16% Drop - 富途牛牛
Does Jade Biosciences, Inc. (JBIO) have the potential to rally 65% as Wall Street analysts expect? - MSN
The recent drop in prices must have disappointed Jade Biosciences, Inc. (NASDAQ:JBIO) institutional investors who own 53% of the shares - simplywall.st
Institutional investors in Jade Biosciences, Inc. (NASDAQ:JBIO) must be dismayed after prices dropped by 16% last week - Yahoo Finance
Jade Biosciences outlines 2026 clinical pipeline and milestones By Investing.com - Investing.com Nigeria
Jade Biosciences (NASDAQ:JBIO) Shares Gap DownTime to Sell? - MarketBeat
Jade Biosciences Outlines 2026 Autoimmune Pipeline Priorities - TipRanks
Jade Biosciences outlines 2026 clinical pipeline and milestones - Investing.com
Jade Biosciences Outlines Key 2026 Objectives and Strategy - GlobeNewswire
Jade Biosciences (NASDAQ:JBIO) Trading Down 3.7%Here's Why - MarketBeat
Jade Biosciences (NASDAQ:JBIO) Stock Price Up 4.5%Here's What Happened - MarketBeat
Wedbush Adjusts Price Target on Jade Biosciences to $24 From $19, Maintains Outperform Rating - MarketScreener
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Volume Report: Why Jade Biosciences Inc stock is popular among millennials2025 Technical Patterns & Daily Growth Stock Tips - moha.gov.vn
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Jade Biosciences files for offering of 3.2 million shares of common stock by selling stockholderSEC filing - marketscreener.com
Jade Biosciences (NASDAQ:JBIO) Trading Down 4.5%Here's What Happened - MarketBeat
What analysts say about Jade Biosciences Inc stockStock Liquidity Analysis & Unlock Long-Term Capital Growth Ideas - earlytimes.in
Jade Biosciences Inc JBIO’s stock price gains traction on Friday - uspostnews.com
Is Jade Biosciences Inc. stock supported by strong cash flowsGap Down & Real-Time Chart Pattern Alerts - Улправда
Why Jade Biosciences Inc. stock is a value investor pickPortfolio Return Report & Accurate Intraday Trading Signals - Улправда
Is Jade Biosciences Inc. stock resilient to inflationWeekly Trade Recap & Capital Protection Trading Alerts - Улправда
Form 424B3 Jade Biosciences, Inc. - StreetInsider
Published on: 2025-12-19 20:08:24 - Улправда
Is Jade Biosciences Inc. stock a safe investment in uncertain marketsGap Up & AI Forecasted Entry/Exit Points - Улправда
Jade Biosciences Inc (JBIO) 財務データ
Jade Biosciences Inc (JBIO) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
3.31%
2.05%
大文字化:
|
ボリューム (24 時間):